XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.2
EQUITY-BASED COMPENSATION - Narrative (Details) - USD ($)
6 Months Ended
Sep. 10, 2019
Jun. 30, 2020
Dec. 31, 2019
Jul. 19, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares outstanding   322,233 166,233  
Number of stock options granted (shares) 182,000 182,000    
Fair value   $ 92,007    
Unrecognized compensation cost, options   $ 395,612    
Unrecognized compensation cost, recognition period   2 years 11 months 15 days    
Flex Pharma        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares outstanding   65,151   90,279
Employee stock option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock options, contractual term   10 years    
Minimum | Employee stock option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period   1 year    
Maximum | Employee stock option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period   4 years    
2015 Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares remaining available for grant of stock awards (shares)   50,087